The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?

Tjeerd Van Staa; Tjeerd-Pieter van Staa; Liam Smeeth; Edmond S-W Ng; Ben Goldacre; Martin Gulliford

doi:10.1136/heartjnl-2013-303698

The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?

Tjeerd Van Staa, Tjeerd-Pieter van Staa, Liam Smeeth, Edmond S-W Ng, Ben Goldacre, Martin Gulliford

Research output: Contribution to journal › Article › peer-review

Abstract

OBJECTIVE: To evaluate targeting of statin prescribing for primary prevention to those with high cardiovascular disease (CVD) risk. DESIGN: Two cohort studies including the general population and initiators of statins aged 35-74 years. SETTING: UK primary care records in the Clinical Practice Research Datalink. PATIENTS: 3.8 million general population patients and 300 914 statin users. INTERVENTION: Statin prescribing. MAIN OUTCOME MEASURES: Statin prescribing by CVD risk; observed 5-year CVD risks; variability between practices. RESULTS: Statin prescribing increased substantially over time to patients with high 10-year CVD risk (≥ 20%): 7.0% of these received a statin prior to 2007, and 30.4% in 2007 onwards. Prescribing to patients with low risk (

Original language	English
Journal	Heart (British Cardiac Society)
Volume	99
Issue number	21
DOIs	https://doi.org/10.1136/heartjnl-2013-303698
Publication status	Published - Nov 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/heartjnl-2013-303698

Cite this

@article{41a21450f98647878c8da5505df0e3bf,

title = "The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?",

abstract = "OBJECTIVE: To evaluate targeting of statin prescribing for primary prevention to those with high cardiovascular disease (CVD) risk. DESIGN: Two cohort studies including the general population and initiators of statins aged 35-74 years. SETTING: UK primary care records in the Clinical Practice Research Datalink. PATIENTS: 3.8 million general population patients and 300 914 statin users. INTERVENTION: Statin prescribing. MAIN OUTCOME MEASURES: Statin prescribing by CVD risk; observed 5-year CVD risks; variability between practices. RESULTS: Statin prescribing increased substantially over time to patients with high 10-year CVD risk (≥ 20%): 7.0% of these received a statin prior to 2007, and 30.4% in 2007 onwards. Prescribing to patients with low risk (",

author = "{Van Staa}, Tjeerd and {van Staa}, Tjeerd-Pieter and Liam Smeeth and Ng, {Edmond S-W} and Ben Goldacre and Martin Gulliford",

note = "098504, Wellcome Trust, United KingdomMR/K006584/1, Medical Research Council, United KingdomWT086136MA, Wellcome Trust, United Kingdom",

year = "2013",

month = nov,

doi = "10.1136/heartjnl-2013-303698",

language = "English",

volume = "99",

journal = "Heart (British Cardiac Society)",

issn = "1468-201X",